HomeCompany NewsUS FDA approves Urogen's bladder cancer drug Company NewsHealthIsraelMiddle EastN2:BIODRGN2:CNCERN2:HECAN2:MEDREGN2:MRCHN2:PHMRN2:PUBLsubj:04002006subj:04016000subj:07000000subj:07001004subj:07013000subj:13019000 US FDA approves Urogen’s bladder cancer drug June 12, 2025 0 43 Share FacebookTwitterPinterestWhatsApp Signage is seen outside of FDA headquarters in White Oak, Maryland (Reuters) -The U.S. Food and Drug Administration has approved Urogen Pharma's drug to treat a type of bladder cancer, the regulator said on Thursday. (Reporting by Padmanabhan Ananthan and Kamal Choudhury in Bengaluru; Editing by Leroy Leo) Hi, I'm Reuters Share FacebookTwitterPinterestWhatsApp Previous articleUS sues New York over law blocking immigration enforcement near courtNext articleTunisia sentences prominent opposition figure Abir Moussi to two years in prison RELATED ARTICLES America Netanyahu faces far-right backlash as Trump presses to end Gaza war October 5, 2025 America Gazans long for end to war, Rubio says not yet October 5, 2025 Middle East Syrian electors cast ballots in indirect vote for first post-Assad parliament October 5, 2025 Most Popular Netanyahu faces far-right backlash as Trump presses to end Gaza war October 5, 2025 Gazans long for end to war, Rubio says not yet October 5, 2025 Georgian PM says protesters aimed to topple the government, accuses EU of meddling October 5, 2025 Border Patrol agents shoot armed woman in Chicago as protesters confront immigration personnel October 5, 2025 Hegseth says he has every authorization needed for Caribbean strikes October 5, 2025 Syrian electors cast ballots in indirect vote for first post-Assad parliament October 5, 2025 Load more